Ayu Watanabe Selected Research

apremilast

10/2021

Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayu Watanabe Research Topics

Disease

4	Atopic Dermatitis (Atopic Eczema) 02/2024 - 06/2019
2	Alopecia Areata 11/2023 - 06/2019
1	Focal Infection 03/2024
1	Inflammation (Inflammations) 02/2023
1	Neoplasms (Cancer) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021
1	Dermatitis 10/2021

Drug/Important Bio-Agent (IBA)

3	dupilumabIBA 02/2024 - 06/2019
1	baricitinibIBA 11/2023
1	upadacitinibIBA 11/2023
1	Biomarkers (Surrogate Marker)IBA 02/2023
1	Immune Checkpoint InhibitorsIBA 01/2022
1	InterleukinsIBA 10/2021
1	apremilastIBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	Interleukin-10 (Interleukin 10)IBA 10/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	Interleukin-22 (IL-22)IBA 10/2021
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2021
1	EnzymesIBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 10/2021

Therapy/Procedure

1	Phototherapy (Light Therapy) 03/2024